Table 4 Clinical characteristics of baseline patients in the high-risk and low-risk groups (IFN-γ)
Baseline characteristics | High-risk group (n = 16) | Low-risk group (n = 15) | P |
|---|---|---|---|
Sex (male: female) | 12:4 | 12:3 | 0.739 |
Age (years) | 59 (44–74) | 61 (37–83) | 0.579 |
Child–pugh (5:6) | 15:1 | 13:2 | 0.953 |
TBIL (µmol/L) | 16.3 (8.6–26.5) | 17.3 (6.1–37.1) | 0.540 |
AIB (g/L) | 39.2 (33.6–42.8) | 40.1 (32.9–48.7) | 0.477 |
PLT (× 109/L) | 139.9 (59–316) | 153.4 (80–232) | 0.332 |
PTA (%) | 83 (71–95) | 91.6 (69–108) | 0.018 |
Etiology (HBV) | HBV (100%) | HBV (100%) |  > 0.999 |
Diameter of HCC (mm) | 24 (9–40) | 18 (9–39) | 0.477 |
AFP (ng/ml) | 69.0 (2.05–818) | 1196.2 (1.55–17,694) | 0.331 |
BCLC staging | A (100%) | A (100%) |  > 0.999 |
HBV-DNA (copies/ml) | 670.9 (10–8015) | 52.3 (10–253) | 0.246 |